CN1470268A - 复方龙血竭及其制备方法 - Google Patents
复方龙血竭及其制备方法 Download PDFInfo
- Publication number
- CN1470268A CN1470268A CNA031177719A CN03117771A CN1470268A CN 1470268 A CN1470268 A CN 1470268A CN A031177719 A CNA031177719 A CN A031177719A CN 03117771 A CN03117771 A CN 03117771A CN 1470268 A CN1470268 A CN 1470268A
- Authority
- CN
- China
- Prior art keywords
- blood
- radix notoginseng
- compound
- powder
- sanguis draxonis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims description 9
- 241000239226 Scorpiones Species 0.000 title 1
- 239000009136 dragon's blood Substances 0.000 claims abstract description 27
- 239000000843 powder Substances 0.000 claims abstract description 27
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 12
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 7
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 5
- 239000002775 capsule Substances 0.000 claims abstract description 4
- 239000007788 liquid Substances 0.000 claims abstract description 3
- 239000003826 tablet Substances 0.000 claims abstract description 3
- 241000180649 Panax notoginseng Species 0.000 claims description 25
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 25
- 241001043298 Croton draco Species 0.000 claims description 22
- 239000009286 sanguis draxonis Substances 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 240000004824 Trimezia steyermarkii Species 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 208000029078 coronary artery disease Diseases 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 238000002347 injection Methods 0.000 abstract description 2
- 239000007924 injection Substances 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 2
- 229940116229 borneol Drugs 0.000 abstract 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 2
- 229930189092 Notoginsenoside Natural products 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 20
- 230000000694 effects Effects 0.000 description 18
- 239000003146 anticoagulant agent Substances 0.000 description 8
- 230000000857 drug effect Effects 0.000 description 8
- 208000007536 Thrombosis Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000002537 thrombolytic effect Effects 0.000 description 5
- 230000000302 ischemic effect Effects 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- 208000031225 myocardial ischemia Diseases 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- XPCFTKFZXHTYIP-PMACEKPBSA-N Benazepril Chemical compound C([C@@H](C(=O)OCC)N[C@@H]1C(N(CC(O)=O)C2=CC=CC=C2CC1)=O)CC1=CC=CC=C1 XPCFTKFZXHTYIP-PMACEKPBSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 208000005189 Embolism Diseases 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 208000001435 Thromboembolism Diseases 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 229960004530 benazepril Drugs 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000035487 diastolic blood pressure Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000036284 oxygen consumption Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 241000746976 Agavaceae Species 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241001561260 Dracaena cambodiana Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000008899 fufang danshen Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940039009 isoproterenol Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031177719A CN1255151C (zh) | 2003-04-25 | 2003-04-25 | 复方龙血竭及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031177719A CN1255151C (zh) | 2003-04-25 | 2003-04-25 | 复方龙血竭及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1470268A true CN1470268A (zh) | 2004-01-28 |
CN1255151C CN1255151C (zh) | 2006-05-10 |
Family
ID=34152697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031177719A Expired - Lifetime CN1255151C (zh) | 2003-04-25 | 2003-04-25 | 复方龙血竭及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1255151C (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100417387C (zh) * | 2004-06-17 | 2008-09-10 | 秦引林 | 一种由冰片和三七总皂苷组成的复方注射制剂及其制备方法 |
CN100531559C (zh) * | 2007-04-12 | 2009-08-26 | 中国热带农业科学院热带生物技术研究所 | 一种人工栽培龙血树诱导生产血竭的方法 |
CN101396495B (zh) * | 2007-09-26 | 2011-03-30 | 王玉朝 | 一种治疗心脑血管疾病的中药 |
CN116407518A (zh) * | 2021-12-31 | 2023-07-11 | 云南圣科药业有限公司 | 三七龙血竭胶囊的制备方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102028834B (zh) * | 2010-11-23 | 2012-07-04 | 云南云河药业有限公司 | 一种复方龙血竭制剂及其制备方法 |
-
2003
- 2003-04-25 CN CNB031177719A patent/CN1255151C/zh not_active Expired - Lifetime
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100417387C (zh) * | 2004-06-17 | 2008-09-10 | 秦引林 | 一种由冰片和三七总皂苷组成的复方注射制剂及其制备方法 |
CN100531559C (zh) * | 2007-04-12 | 2009-08-26 | 中国热带农业科学院热带生物技术研究所 | 一种人工栽培龙血树诱导生产血竭的方法 |
CN101396495B (zh) * | 2007-09-26 | 2011-03-30 | 王玉朝 | 一种治疗心脑血管疾病的中药 |
CN116407518A (zh) * | 2021-12-31 | 2023-07-11 | 云南圣科药业有限公司 | 三七龙血竭胶囊的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1255151C (zh) | 2006-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100382839C (zh) | 一种治疗冠心病的中药组合物 | |
CN101843661B (zh) | 一种治疗心绞痛的中药 | |
CN1255151C (zh) | 复方龙血竭及其制备方法 | |
CN1304769A (zh) | 清血丸 | |
CN1060344C (zh) | 治疗缺血性脑血管、心血管的药物制剂 | |
CN1943620B (zh) | 一种治疗心脑血管疾病的中药组合物及其制备方法 | |
CN1733031A (zh) | 脑得生口服液及其制备方法 | |
CN101167838B (zh) | 一种治疗冠心病心绞痛的中药制剂及其制备方法 | |
CN100493543C (zh) | 一种用于戒毒的中药胶囊制剂及其制备方法 | |
CN101559161B (zh) | 一种中药组合物在制备治疗抑郁症药物中的应用 | |
CN1182862C (zh) | 一种治疗冠心病心绞痛的中药制剂及其制备方法 | |
CN1686198A (zh) | 以三七、丹参和灯盏花提取物制备的口服药物制剂 | |
CN1245197C (zh) | 治疗冠心病、病毒性心肌炎的中药制剂 | |
CN102370735B (zh) | 一种中药组合物在制备治疗红细胞增多症药物中的应用 | |
CN102204956A (zh) | 一种用于中风恢复期的中药组合物及其制备方法 | |
CN102327304A (zh) | 一种防治慢性高原病的药物及其制备方法 | |
CN101732637A (zh) | 一种治疗心脑血管疾病的中药 | |
CN1094620A (zh) | 治疗食管癌的中成药刘氏化癌回香丹 | |
CN111068004A (zh) | 一种降压调脂的中药组合物 | |
CN100344322C (zh) | 治疗心脏病的药物及其制备方法 | |
CN1159028C (zh) | 一种治疗凝血酶原减少所致的各种出血性疾病的中药 | |
CN1057008C (zh) | 茶色素在制备治疗病毒性心肌炎药物中的应用 | |
CN1548123A (zh) | 抗流感药物 | |
CN101843835B (zh) | 一种治疗冠心病的中药 | |
CN101843672B (zh) | 一种治疗动脉硬化的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Compound Longxue scorpion and preparation method thereof Effective date of registration: 20110623 Granted publication date: 20060510 Pledgee: China Development Bank Co. Yunnan branch Pledgor: Yunnan Yunhe Pharmaceuticals Co.,Ltd. Registration number: 2011990000236 |
|
C56 | Change in the name or address of the patentee |
Owner name: YUNNAN YUNHE PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: YUNHE PHARAMCEUTICAL CO., LTD., YUNNAN |
|
CP03 | Change of name, title or address |
Address after: 661000, 1 Honghe Road, Gejiu City, Honghe Hani and Yi Autonomous Prefecture, Yunnan Province Patentee after: YUNNAN YUNHE PHARMACEUTICALS Inc. Address before: 661000 old Yangshan, Gejiu City, Yunnan Patentee before: Yunnan Yunhe Pharmaceuticals Co.,Ltd. |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20160608 Granted publication date: 20060510 Pledgee: China Development Bank Co. Yunnan branch Pledgor: YUNNAN YUNHE PHARMACEUTICALS INC. Registration number: 2011990000236 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PM01 | Change of the registration of the contract for pledge of patent right |
Change date: 20160608 Registration number: 2011990000236 Pledgor after: YUNNAN YUNHE PHARMACEUTICALS Inc. Pledgor before: Yunnan Yunhe Pharmaceuticals Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Compound Longxue scorpion and preparation method thereof Effective date of registration: 20160706 Granted publication date: 20060510 Pledgee: Yun energy financing lease (Shanghai) Co.,Ltd. Pledgor: YUNNAN YUNHE PHARMACEUTICALS INC. Registration number: 2016530000011 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210719 Granted publication date: 20060510 Pledgee: Yun energy financing lease (Shanghai) Co.,Ltd. Pledgor: YUNNAN YUNHE PHARMACEUTICALS Inc. Registration number: 2016530000011 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Compound dragon's blood dragon and its preparation method Effective date of registration: 20220224 Granted publication date: 20060510 Pledgee: Gejiu Rural Credit Cooperative Association Pledgor: YUNNAN YUNHE PHARMACEUTICALS Inc. Registration number: Y2022530000007 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
CX01 | Expiry of patent term |
Granted publication date: 20060510 |
|
CX01 | Expiry of patent term | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20060510 Pledgee: Gejiu Rural Credit Cooperative Association Pledgor: YUNNAN YUNHE PHARMACEUTICALS Inc. Registration number: Y2022530000007 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |